Followers | 145 |
Posts | 27565 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Monday, May 06, 2013 9:08:24 AM
Monday 6 May 2013
Given Imaging (Nasdaq:GIVN) today announced that the company will host a meeting with members of the financial community on Tuesday, May 21st, 2013 to review PillCam COLON 2 U.S. pivotal trial data and other highlights from Digestive Disease Week 2013, taking place in Orlando, FL, May 18 – 21, 2013. The meeting will take place at 10:00am ET, 5:00pm Israel time.
Homi Shamir, President and CEO of Given Imaging will be joined by Dr. Samuel Adler, Chief, Division of Gastroenterology, Bikur Holim Hospital, Jerusalem, Dr. Douglas K. Rex, Distinguished Professor of Medicine, Indiana University School of Medicine, and Dr. Cristiano Spada, Digestive Endoscopy Unit, Catholic University of Rome, Italy.
A live audio webcast will be available in the investor relations section of the company's website, www.givenimaging.com. To participate in the live teleconference, please dial the following numbers approximately fifteen minutes prior to the start of the meeting: U.S. and Canada, 877-334-1964 (toll-free); callers in other countries should dial, 631-291-4574 (toll charges apply). The archived webcast will be available for thirty days on the company's website.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM